Outpatient Treatment with AZD7442 (Tixagevimab/Cilgavimab) Prevented COVID-19 Hospitalizations over 6 Months and Reduced Symptom Progression in the TACKLE Randomized Trial
- Publication date
- 26 September 2023
- Publisher
- 'Springer Science and Business Media LLC'